Background/Aims: The -1082A>G polymorphism (rs1800896) in the interleukin-10 (IL10) gene has been associated with type 2 diabetes and diabetic retinopathy, but its relationship with diabetic kidney disease (DKD) is uncertain. The aim of this case-control study was to investigate whether the -1082A>G polymorphism is associated with DKD in white Brazilians with type 2 diabetes mellitus. Methods: Genotyping was done by real-time polymerase chain reaction for 597 type 2 diabetic outpatients. The definition of DKD was based on estimated glomerular filtration rate (eGFR) and albuminuria, and the patients were grouped in three categories: no DKD (n=249), mild to moderate DKD (n=222), and severe DKD (n=126). Results: The frequency of the minor (G) allele in subjects without DKD did not differ from that observed in subjects with DKD (0.35 vs 0.39, respectively; P = 0.192). Genotype frequencies in subjects without DKD were not significantly different from those observed among patients with mild to moderate DKD or severe DKD. However, considering only the eGFR categories as an indicator of renal function, the AG genotype was independently associated with an increased risk of mildly to moderately decreased eGFR (G3a category) and GG genotype was independently associated with increased risk of kidney failure (G5 category) as compared with AA genotype. Conclusion: Our findings support the hypothesis that the -1082A>G polymorphism in the IL10 gene might be associated with DKD in white Brazilians with type 2 diabetes.
Introduction
Diabetic kidney disease (DKD) is a syndrome characterized by structural and functional changes with reduced estimated glomerular filtration rate (eGFR) and/or albuminuria. It occurs in 10-40% of type 2 diabetic patients and is the leading cause of end-stage renal disease (ESRD) [1] . Besides ESRD, lower GFR and higher levels of albuminuria are independently associated with acute kidney injury, cardiovascular mortality, and all-cause mortality [2, 3] . Longer duration of diabetes, poor glycemic control, and hypertension are the most common risk factors for DKD and its progression. Even so, the prevalence of DKD varies with ethnicity and individual risk of DKD is influenced by genetic predisposition [4, 5] .
The early phase of DKD is characterized by glomerular hyperfiltration, followed by progressive morphological and ultrastructural changes, including the mesangial expansion, thickening of the basement membrane, nodular glomerulosclerosis, and loss of podocytes [1] . Such changes are promoted in the diabetic milieu, as hemodynamic alterations, metabolic derangements, and endothelial dysfunction trigger cell signaling cascades that lead renal cells to produce chemokines, growth factors, adhesion molecules, and inflammatory cytokines. This, in turn, results in the recruitment, differentiation, proliferation, activation, and infiltration of monocytes/macrophages and T lymphocytes into the kidney, contributing to a cycle of inflammation, oxidative stress, cellular injury, progressive fibrosis, and loss of GFR [1, 6, 7] .
Inflammation has been increasingly recognized as having a central role in the onset and progression of DKD. Circulating levels of proinflammatory cytokines are increased in diabetic patients and correlate with progressive albuminuria [7] . Interleukin-10 (IL-10) is a multifunctional cytokine that exerts predominantly anti-inflammatory effects by inhibiting the production of proinflammatory cytokines, antigen presentation, and proliferation of T cells. Depending on the circumstances and the cell type, IL-10 may exert immunostimulatory effects by upregulating MHC class II expression on B lymphocytes. IL-10 is expressed by most immune cells, but is not restricted to them [8, 9] . Chen et al [6] . demonstrated that kidney tissue isolated from diabetic patients express more IL-10 than the kidney tissue isolated from non-diabetic subjects. In type 2 diabetic Chinese patients, serum levels of IL-10 were increased in those with macroalbuminuria and positively related to the urinary albuminto-creatinine ratio (UACR) [10] . In contrast, urinary IL-10 concentration was inversely correlated with UACR in normoalbuminuric Brazilians with type 2 diabetes [11] .
The levels of IL-10 are highly variable in healthy individuals [12, 13] and are regulated by functional variants in the gene encoding IL-10 (IL10), such as the -1082A>G (rs1800896) polymorphism in the promoter region [13] . This polymorphism has been reported to be associated with type 2 diabetes [14] , renovascular disease [15] , and clinical outcomes in endstage renal disease [16] . We recently showed that the -1082A>G polymorphism is associated with diabetic retinopathy in type 2 diabetic patients (unpublished data). Previous studies that evaluated the relationship between this polymorphism and kidney disease in diabetic patients have obtained conflicting results [17] [18] [19] [20] [21] [22] . Therefore, we aimed to investigate whether the -1082A>G polymorphism (rs1800896) in the IL10 gene is associated with diabetic kidney disease in white Brazilians with type 2 diabetes mellitus.
Materials and Methods

Subjects
This case-control study was carried out with 597 subjects with type 2 diabetes who regularly attend the endocrinology outpatient clinics of four public hospitals in Rio Grande do Sul State, in Southern Brazil (Hospital de Clínicas de Porto Alegre, Hospital Nossa Senhora da Conceição, Hospital São Vicente de Paulo, and Fundação Universitária de Rio Grande). Five hundred and forty-seven patients were enrolled between 2000 and 2010, and 50 patients were included in the study in 2015 or 2016. Type 2 diabetes was defined according to the guidelines of the American Diabetes Association [23] , and the inclusion criteria were age ≥ 30 years at the diagnosis of diabetes, no need of permanent insulin treatment within the first year of diagnosis, and no previous episodes of ketoacidosis. Moreover, all patients classified as having no kidney disease had to have diabetes for at least 5 years to be included in the study. No other inclusion or exclusion criteria were used. All subjects were self-declared white Brazilians of European (Caucasian) ancestry, mainly from Portugal, Spain, Italy, and Germany. The study was approved by the hospital ethics committees and all patients participating in this study provided written informed consent.
Clinical and laboratory evaluation
All patients underwent a comprehensible physical and laboratory evaluation, as previously described in detail [24, 25] . A questionnaire was used to collect data about their medical history, such as the age at diabetes diagnosis, smoking history, and use of medication. Diabetic retinopathy was evaluated by direct fundoscopy under mydriasis, and fluorescein angiography was done when indicated. The diagnosis of DKD was based on estimated glomerular filtration rate (eGFR) and albuminuria according to the KDIGO 2012 classification [2] . Serum creatinine was measured by the Jaffé reaction, and albuminuria was measured by immunoturbidimetry [24] in the absence of conditions that could interfere with albumin measurement, such as fever and urinary tract infection. GFR was estimated using the CKD-EPI formula [26] , and albuminuria was based on at least two of three consecutive timed urine collections (µg/min) or random spot urine samples (mg/L) for 64% and 36% of the patients, respectively. Patients were then grouped in three categories: no kidney disease, mild to moderate kidney disease, and severe kidney disease (Table 1) .
In relation to macrovascular disease, most patients were clinically evaluated for the presence of ischemic heart disease (n=451), peripheral vascular disease (n=451), and stroke (n=416). Ischemic heart disease was defined in the presence of angina or possible infarct according to the World Health Organization (WHO) Cardiovascular Questionnaire and/or the presence of resting electrocardiogram abnormalities and/ or the presence of perfusion abnormalities on myocardial scintigraphy. Peripheral vascular disease was diagnosed by the presence of intermittent claudication according to the World Health Organization (WHO) Cardiovascular Questionnaire and/or the absence of foot pulses. Stroke, which was identified by previous history and/or the presence of sequels, was not evaluated in the endocrinology outpatient clinics of Hospital Nossa Senhora da Conceição. 
Genotyping
Genomic DNA was isolated from peripheral blood leukocytes by the salting out method, as described by Lahiri and Nurnberger Jr [27] . The -1082A>G polymorphism in the IL10 gene was genotyped by realtime polymerase chain reaction (PCR) using proprietary primers and probes (TaqMan® Genotyping Assay, assay ID: C_1747360_10; Thermo Fisher Scientific, Waltham, USA). Amplification reactions were done in optical tubes, in a 10 µL total volume, containing 2 ng of genomic DNA, TaqMan® Genotyping Master Mix 1X, and Genotyping Assay 1X (Thermo Fisher Scientific). Optical tubes were loaded into a real-time PCR thermal cycler and heated for 10 min at 95ºC, followed by 40 cycles of 95ºC for 15 s, and 60ºC for 1 min. Files with the fluorescence data collected during the amplification runs were analyzed with the StepOne software version 2.3 (Thermo Fisher Scientific). Samples with known genotypes were used in each run and the investigator who performed the genotyping was blinded to the patients' renal status, clinical condition, and laboratory data. To ensure the accuracy of the genotyping results, genotypes were determined independently by two investigators, and ambiguous samples were re-genotyped or discarded.
Statistical analysis
Demographic, clinical, laboratory, and genetic data are expressed as means ± standard deviation (SD), medians (25 th -75 th percentiles), absolute frequencies (percentages), or relative frequencies. The normality of continuous variables was verified using the Shapiro-Wilk test. Continuous data were compared between groups by ANOVA or Kruskal-Wallis tests, followed by the Tukey or Dunn post-hoc tests, as appropriate. The chi-square test was used to compare the categorical variables, including the genotype and allele frequencies, between groups. The Yates correction was applied for the comparisons involving 2x2 contingency tables, and P values computed for the analysis of contingency tables larger than 2x2 were corrected for multiple pairwise comparisons with the Bonferroni formula. The chi-square test was also used to test for HardyWeinberg equilibrium. Logistic regression analysis was done to test for association of the -1082A>G polymorphism with DKD, adjusting for the covariates that were also associated with it in the univariate analyses. Statistical analyses were done using SPSS (version 18.0; SPSS Inc., Chicago, USA) and WinPEPI (version 11.43) [28] statistical softwares. A two-tailed P value < 0.05 was considered statistically significant.
Results
Characteristics of the patients according to the renal status
Based on the levels of eGFR and albuminuria, this study involved 249 patients without DKD and 348 patients with some degree of DKD. Briefly, patients with severe DKD were more often male, had diabetes for longer, higher prevalence of insulin therapy, hypertension, diabetic retinopathy, ischemic heart disease, peripheral vascular disease, and stroke than patients without DKD. They were also leaner, had higher levels of systolic blood pressure, serum creatinine, urinary albumin excretion rate, eGFR, and had lower levels of glycated hemoglobin and HDL cholesterol as compared with patients without DKD (Table 2) .
Overall, in the population studied the frequencies of the AA, AG, and GG genotypes were 37.5%, 49.8%, and 12.7%, respectively. The frequency of the minor (G) allele was 37.6%. As shown in Table 2 , the genotype and allele frequencies in patients without DKD were not significantly different from those observed in patients with mild/moderate or severe DKD. Genotype frequencies of the -1082A>G polymorphism did not deviate from those predicted by Hardy-Weinberg equilibrium in all groups of subjects.
Characteristics of the patients according to the -1082A>G polymorphism
Demographic and clinical profile of patients with different genotypes of -1082A>G polymorphism was similar for most characteristics (Table 3) . However, subjects with the AA genotype had higher glycated hemoglobin levels than those with AG genotype, whereas patients with GG genotype were more often taking beta-blockers as compared with those with other genotypes. Although it did not reach statistical significance, subjects with GG (Table 3) . Then, we decided to assess the relationship between the -1082A>G polymorphism and DKD, as defined by eGFR categories.
Association between the -1082A>G polymorphism and eGFR categories
Considering the six categories of DKD defined according to the eGFR values, we observed an increased frequency of AG and GG genotypes in patients with mildly to moderately decreased eGFR (G3a) and in those with kidney failure (G5), respectively, as compared with patients with normal or high eGFR (G1). Moreover, the G allele was more frequent in subjects with kidney failure (G5) than in those with normal or high eGFR (G1) ( Table 4 ). However, these statistical differences were lost after correction for multiple pairwise comparisons.
Next, we tested the association of the -1082A>G polymorphism with mildly to moderately decreased eGFR (G3a) and kidney failure (G5), using four genetic models (codominant, dominant, recessive, and overdominant) and assuming the G allele as the risk allele. In relation to mildly to moderately decreased eGFR (G3a), the G allele was associated with increased risk of DKD under the dominant and codominant models, even after adjusting for the covariates that were also associated with this outcome in the univariate analyses (Table 5) . Similarly, the G allele was associated with increased risk of kidney failure under the dominant, recessive, and codominant models after adjusting for the covariates that were also associated with it (Table 6 ).
Discussion
In this study, we investigated whether the -1082A>G polymorphism (rs1800896) in the IL10 gene is associated with the presence or severity of DKD in white type 2 diabetic patients from Southern Brazil. Using both albuminuria and eGFR categories to define DKD, we failed to detect an association with this polymorphism. However, when considering only the eGFR categories, the G allele was independently associated with an increased risk of mildly to moderately decreased eGFR (G3a) and kidney failure (G5). We tested four genetic models and some of them revealed statistically significant associations with eGFR categories G3a and G5. Identifying which model is the correct one is hampered by the small number of subjects in G3a and G5 categories and the low frequency of the GG genotype. This may have led to some false positive associations and the loss of others. Combining the results of the analysis of adjusted residuals and the logistic regression models, we identified that the AG genotype was associated with mildly to moderately decreased eGFR (G3a), whereas GG genotype was associated with increased risk of kidney failure (G5) as compared with AA genotype, under the codominant model for both outcomes. These findings are in accordance with a previous Brazilian study that found a higher frequency of the heterozygous genotype (AG) in patients with diabetic nephropathy (DN) than in those with normoalbuminuria in a population of type 2 diabetic patients from the Southeast region [21] . The AG genotype was also associated with urine protein ≥ 3.5 g/24h among patients with IgA nephropathy in a Han Chinese population [29] . Moreover, the GG genotype was associated with an increased risk of DN and ESRD in Caucasians from Germany [17] . However, other studies conducted on Tunisian [18] , Taiwanese [19] , and Turkish [20] patients with type 2 diabetes did not find such an association. Similarly, no association was observed between the -1082A>G polymorphism and ESRD in white Europeans [30] and Czechs [31] . Conversely, the AA genotype was associated with the increased risk of ESRD in north Indian [32] and Chinese [33] populations. This same genotype was associated with nephropathy in Chinese type 2 diabetic patients as compared with subjects without both diabetes and kidney disease [22] . Interleukin-10 plays an important role in the regulation and maintenance of normal renal function, and abnormal IL-10 expression contributes to acute kidney injury and progressive chronic renal failure. In the kidney, IL-10 is mainly expressed in the mesangial and endothelial cells, where it acts as an autocrine cell growth factor [34] . As reviewed by Sinuani et al [34] ., IL-10 induces the proliferation of mesangial cells through an increased production of growth factors, cytokines, and chemokines. This leads to structural intraglomerular and tubulointerstitial changes, such as cell hypertrophy, thickening of the glomerular basement membrane, accumulation of mesangial matrix, and overt proteinuria. These pathological changes, in turn, lead to renal failure and ESRD. Considering that the main function of IL-10 is to control inflammation [8, 9, 34] , this scenario seems to be a paradox, as the low expression of IL-10 would be expected to be detrimental to renal function due to the loss of anti-inflammatory protection.
In line with this assumption, serum levels of IL-10 were lower in Chinese patients with ESRD as compared with healthy individuals. In addition, the AA genotype was associated with the increased risk of ESRD, and among patients, the serum levels of IL-10 in homozygotes for the A allele of the -1082A>G polymorphism were lower than in the G allele carriers [33] . However, the up-regulation of IL-10 has been associated with various kidney diseases [34] and high circulating IL-10 levels were found in diabetic patients [19, 34] and in those with macroalbuminuria or chronic kidney disease in type 2 diabetes [10] . In this context, Almeida et al [35] . reported that a session of hemodialysis in type 2 diabetic patients modulates the T cell activation status and increases the IL-10 serum levels. Evidences from experimental studies show that under certain conditions, IL-10 has protective effects, reducing kidney damage, but in other circumstances, it can worsen the renal function [34] .
The identification of specific gene variants that confer predisposition to DKD is complicated mainly by inadequate sample size, heterogeneity in the definition of DKD (which leads to case-control misclassification) [4] , and inclusion/exclusion clinical criteria adopted in the association studies [17] [18] [19] [20] [21] [22] . Recently, attention has been given to the distinction between DKD defined by albuminuria and DKD defined by eGFR. Albuminuria and the decline of eGFR can develop independently of each other, suggesting that different pathological mechanisms and different gene variants may be involved [4] . In our study, albuminuria levels were not different among patients with AA, AG, or GG genotypes, whereas the -1082A>G polymorphism was associated with eGFR categories. Apart from this, without performing renal biopsy it is not possible to assume that type 2 diabetic subjects with albuminuria or low eGFR have DKD. Renal diseases in type 2 diabetes are more complex and heterogeneous, and a broad range of pathological types of renal diseases can occur in type 2 diabetes [5, 36] .
Another issue that should be considered is the coexistence of diabetic retinopathy and DKD [37] . We recently found that the -1082A>G polymorphism is associated with diabetic retinopathy in type 2 diabetic patients (unpublished data). In our population study, 63% of the patients with kidney failure (eGFR category G5) had proliferative diabetic retinopathy, while only 8% of the patients with normal or high eGFR (eGFR category G1) did so. Therefore, we cannot rule out the possibility that the association between GG genotype and kidney failure observed in our study is confounded by the occurrence of proliferative diabetic retinopathy. Although our study has the inherent limitations of a case-control study and odds ratios and their confidence intervals are overestimated, our findings suggest that the -1082A>G polymorphism might be associated with decreased eGFR and should be investigated further.
Conclusion
In summary, this study showed that the AG genotype was independently associated with increased risk of mildly to moderately decreased eGFR, whereas GG genotype was independently associated with increased risk of kidney failure as compared with AA genotype. Although these findings are not definitive and need to be replicated in larger studies, taken together, they suggest that the -1082A>G polymorphism (rs1800896) in the IL10 gene is associated with diabetic kidney disease in type 2 diabetic patients from Southern Brazil.
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